Patents by Inventor JÖRG VON HAGEN

JÖRG VON HAGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058456
    Abstract: The present disclosure relates to molecules with a solubility tag, wherein the solubility tag comprises a chito-oligosaccharide, and to methods for increasing the solubility of a molecule. Moreover, the present disclosure relates to antibody-drug conjugates with solubility tag, methods and compounds for preparing such antibody-drug conjugates, methods for increasing the solubility of antibody-drug conjugates, antibody-drug conjugates prepared by such methods, as well as the use of such antibody-drug conjugates in medical treatment.
    Type: Application
    Filed: September 17, 2021
    Publication date: February 22, 2024
    Inventors: Carl Deutsch, Sven Kelly, Helene Crassier, Christoph Korpus, Joerg von Hagen, Ulrike Richter-Sander
  • Publication number: 20230288402
    Abstract: The present invention relates to a method for identifying a pharmaceutically active compound that modulates the rpL35 (rpL35/rpL29)-dependent translation of at least one mRNA in a mammalian cell. The mRNA may comprise a premature termination codon (PTC), undergoes premature translation termination, causes programmed ?1 ribosomal frame shifting (?1PRF), or is a polycistronic mRNA. Furthermore a respective screening system, methods of treating or preventing a disease or condition, and compounds that modulate the rpL35 (rpL35/rpL29)-dependent translation, in particular atazanavir or derivatives thereof and artemisinin or artesunate or derivatives thereof are provided.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 14, 2023
    Inventors: HANNELORE BREITENBACH-KOLLER, JÖRG VON HAGEN, HELMUT HINTNER, FRIEDRICH LOTTSPEICH, HANS-WERNER MEWES, NORBERT MÜLLER, ANDREAS FRIEDRICH, KATHARINA ELSENSOHN, CLAUDIA MOSSHAMMER, MICHAEL WIESSNER, THOMAS KARL, JAN SCHERNTHANER, ADRIANA RATHNER
  • Patent number: 11737997
    Abstract: The present invention relates to mixtures of serine or threonine together with at least one further amino acid or amino acid derivative and with at least one calcium salt or its hydrate and methods including this mixture including specific mixtures of such components and a formulations consisting of the mixture and a solvent.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: August 29, 2023
    Assignee: Merck Patent GmbH
    Inventors: Alexander Paul Schiller, Lisa Eckelhoefer, Julia Bleifuss, Andrew Philip Salazar, Joerg von Hagen
  • Patent number: 11180610
    Abstract: The present invention relates to the purification of poloxamers to be used as cell culture media additives. Activated carbon can be used to remove hydrophobic high molecular weight components which reduce the efficacy of poloxamers as cell culture additives.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: November 23, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Anja Licht, Almut Rapp, Joerg Von Hagen
  • Publication number: 20210207079
    Abstract: The present invention relates to a process for manufacturing dry powder cell culture media. The preparation and usage of mixed particles generated by co-lyophilisation leads to cell culture media with improved solubility without changing the chemical composition.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Nikolai STANKIEWICZ, Anke SIMON
  • Publication number: 20200405674
    Abstract: The present invention relates to the use of serine or threonine together with at least one further amino acid or amino acid derivative and with at least one calcium salt or its hydrate to increase cellular availability of calcium in living cells of the epidermis and to a specific mixture of such components and a formulation consisting of said mixture and a solvent.
    Type: Application
    Filed: February 20, 2020
    Publication date: December 31, 2020
    Applicant: Merck Patent GmbH
    Inventors: Alexander Paul SCHILLER, Lisa ECKELHOEFER, Julia BLEIFUSS, Andrew Philip SALAZAR, Joerg von HAGEN
  • Patent number: 10731126
    Abstract: The present invention relates to cell culture media compositions comprising deep eutectic solvents and/or ionic liquids.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: August 4, 2020
    Assignee: Merck Patent GmbH
    Inventors: Jochen Bastian Sieck, Michael Howard Rayner, Joerg Von Hagen, Claudia Knack
  • Patent number: 10619131
    Abstract: The present invention relates to cell culture media comprising inorganic ester derivatives of tyrosine and/or cysteine. The poor solubility of tyrosine and the often non-sufficient stability of cysteine in cell culture media is overcome by substituting them with an inorganic ester derivative, e.g. with a phosphorylated derivative.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: April 14, 2020
    Assignee: Merck Patent GmbH
    Inventors: Joerg Von Hagen, Marcel Andre Breuning, Christian Jasper
  • Patent number: 10563169
    Abstract: The present invention relates to dry cell culture media comprising amino acid components of certain particle size. Some dry powder cell culture media show poor dissolving properties and result in turbid solutions when they are dissolved in aqueous solutions. Using amino acid components of certain particle sizes significantly reduces that problem.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: February 18, 2020
    Assignee: Merck Patent GmbH
    Inventor: Joerg Von Hagen
  • Patent number: 10421941
    Abstract: The invention relates to a process for improving the solubility of dry cell culture media. Some dry powder cell culture media show poor dissolving properties and result in turbid solutions when they are dissolved in aqueous solutions. Using a stepwise procedure in which the amino acids present in the non-dissolving part are identified and added to a new batch in other particle sizes significantly reduces that problem.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: September 24, 2019
    Assignee: Merck Patent GmbH
    Inventor: Joerg Von Hagen
  • Publication number: 20190256819
    Abstract: The present invention relates to a process for improving the solubility or dissolution behaviour of components in an aqueous solution. The dissolution properties of a slowly/badly dissolving component can be positively affected by generating mixed particles of this component with another component which has a negative dissolution enthalpy. By preparing and adding such mixed particles solubility is improved without changing the chemical composition.
    Type: Application
    Filed: July 25, 2017
    Publication date: August 22, 2019
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Andrew SALAZAR, Markus LUBDA
  • Publication number: 20190085125
    Abstract: The present invention relates to the purification of poloxamers to be used as cell culture media additives. Activated carbon can be used to remove hydrophobic high molecular weight components which reduce the efficacy of poloxamers as cell culture additives.
    Type: Application
    Filed: February 20, 2017
    Publication date: March 21, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Anja LICHT, Almut RAPP, Joerg VON HAGEN
  • Publication number: 20180355305
    Abstract: The present invention relates to feed media comprising deep eutectic solvents and/or ionic liquids.
    Type: Application
    Filed: May 2, 2016
    Publication date: December 13, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Michael Howard RAYNER, Joerg VON HAGEN, Jochen Bastian SIECK, Claudia KNACK
  • Publication number: 20180230422
    Abstract: The present invention relates to cell culture media comprising inorganic ester derivatives of tyrosine and/or cysteine. The poor solubility of tyrosine and the often non-sufficient stability of cysteine in cell culture media is overcome by substituting them with an inorganic ester derivative, e.g. with a phosphorylated derivative.
    Type: Application
    Filed: April 13, 2018
    Publication date: August 16, 2018
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Marcel Andre BREUNING, Christian JASPER
  • Publication number: 20180223250
    Abstract: The present invention relates to a process for manufacturing dry powder cell culture media. The preparation and usage of mixed particles generated by co-lyophilisation leads to cell culture media with improved solubility without changing the chemical composition.
    Type: Application
    Filed: July 8, 2016
    Publication date: August 9, 2018
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Nikolai STANKIEWICZ, Anke SIMON
  • Patent number: 10030225
    Abstract: The present invention relates to cell culture media comprising inorganic ester derivatives of tyrosine and/or cysteine. The poor solubility of tyrosine and the often non-sufficient stability of cysteine in cell culture media is overcome by substituting them with an inorganic ester derivative, e.g. with a phosphorylated derivative.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: July 24, 2018
    Assignee: Merck Patent GmbH
    Inventors: Joerg Von Hagen, Marcel Andre Breuning, Christian Jasper
  • Publication number: 20180163171
    Abstract: The present invention relates to cell culture media compositions comprising deep eutectic solvents and/or ionic liquids.
    Type: Application
    Filed: May 2, 2016
    Publication date: June 14, 2018
    Applicant: Merck Patent GmbH
    Inventors: Jochen Bastian SIECK, Michael Howard RAYNER, Joerg VON HAGEN, Claudia KNACK
  • Patent number: 9994810
    Abstract: The present invention relates to an a process for manufacturing dry powder cell culture media. The preparation and usage of mixed particles generated by co-lyophilisation leads to homogenously blended cell culture media.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: June 12, 2018
    Assignee: MERCK PATENT GMBH
    Inventor: Joerg Von Hagen
  • Patent number: 9988600
    Abstract: The present invention relates to cell culture media comprising polymer embedded components. Some components show poor stability in dry powder cell culture media. Others are hygroscopic. Such components can be embedded into polymers to increase stability and reduce clumping.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: June 5, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Michael Howard Rayner-Brandes, Joerg Von Hagen
  • Publication number: 20170342372
    Abstract: The present invention relates to dry cell culture media comprising amino acid components of certain particle size. Some dry powder cell culture media show poor dissolving properties and result in turbid solutions when they are dissolved in aqueous solutions. Using amino acid components of certain particle sizes significantly reduces that problem.
    Type: Application
    Filed: November 13, 2015
    Publication date: November 30, 2017
    Applicant: Merck Patent GmbH
    Inventor: Joerg VON HAGEN